A. Scheen, PATHOPHYSIOLOGY OF TYPE 2 DIABETES, Acta Clinica Belgica, vol.4, issue.3, pp.335-341, 2003.
DOI : 10.1179/acb.2003.58.5.010

S. Smith, Central role of the adipocyte in the insulin-sensitising and cardiovascular risk modifying actions of the thiazolidinediones, Biochimie, vol.85, issue.12, pp.1219-1230, 2003.
DOI : 10.1016/j.biochi.2003.10.010

G. Kroder, B. Bossenmaier, M. Kellerer, E. Capp, B. Stoyanov et al., Tumor necrosis factor-alpha- and hyperglycemia-induced insulin resistance. Evidence for different mechanisms and different effects on insulin signaling., Journal of Clinical Investigation, vol.97, issue.6, pp.1471-1477, 1996.
DOI : 10.1172/JCI118569

C. Steppan, S. Bailey, S. Bhat, E. Brown, R. Banerjee et al., The hormone resistin links obesity to diabetes, Nature, vol.409, issue.6818, pp.307-312, 2001.
DOI : 10.1038/35053000

E. Hu, P. Liang, and B. Spiegelman, AdipoQ is a novel adipose-specific gene dysregulated in obesity, J Biol Chem, vol.271, pp.10697-10703, 1996.

G. Hotamisligil, N. Shargill, and B. Spiegelman, Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance, Science, vol.259, issue.5091, pp.87-91, 1993.
DOI : 10.1126/science.7678183

J. Nolan, B. Ludvik, P. Beerdsen, M. Joyce, and J. Olefsky, Improvement in Glucose Tolerance and Insulin Resistance in Obese Subjects Treated with Troglitazone, New England Journal of Medicine, vol.331, issue.18, pp.1188-1193, 1994.
DOI : 10.1056/NEJM199411033311803

J. Lehmann, L. Moore, T. Smith-oliver, W. Wilkison, T. Willson et al., An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor ?? (PPAR??), Journal of Biological Chemistry, vol.270, issue.22, pp.12953-12956, 1995.
DOI : 10.1074/jbc.270.22.12953

A. Berg, T. Combs, X. Du, M. Brownlee, and P. Scherer, The adipocyte-secreted protein Acrp30 enhances hepatic insulin action, Nature Medicine, vol.7, issue.8, pp.947-953, 2001.
DOI : 10.1038/90992

T. Yamauchi, J. Kamon, H. Waki, Y. Terauchi, N. Kubota et al., The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity, Nature Medicine, vol.7, issue.8, pp.941-946, 2001.
DOI : 10.1038/90984
URL : https://hal.archives-ouvertes.fr/hal-00174777

H. Guan, Y. Li, M. Jensen, C. Newgard, C. Steppan et al., A futile metabolic cycle activated in adipocytes by antidiabetic agents, Nature Medicine, vol.50, issue.10, pp.1122-1128, 2002.
DOI : 10.1038/nm0202-179

P. Peraldi, M. Xu, and B. Spiegelman, Thiazolidinediones block tumor necrosis factor-alpha-induced inhibition of insulin signaling., Journal of Clinical Investigation, vol.100, issue.7, pp.1863-1869, 1997.
DOI : 10.1172/JCI119715

M. Rajala, S. Obici, P. Scherer, and L. Rossetti, Adipose-derived resistin and gut-derived resistin-like molecule????? selectively impair insulin action on glucose production, Journal of Clinical Investigation, vol.111, issue.2, pp.225-230, 2003.
DOI : 10.1172/JCI16521
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC151868

C. Yen, B. Beamer, C. Negri, K. Silver, K. Brown et al., Molecular Scanning of the Human Peroxisome Proliferator Activated Receptor ?? (hPPAR??) Gene in Diabetic Caucasians: Identification of a Pro12Ala PPAR??2 Missense Mutation, Biochemical and Biophysical Research Communications, vol.241, issue.2, pp.270-274, 1997.
DOI : 10.1006/bbrc.1997.7798

S. Deeb, L. Fajas, M. Nemoto, J. Pihlajamaki, L. Mykkanen et al., A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity, Nature Genetics, vol.20, issue.3, pp.284-287, 1998.
DOI : 10.1038/3099

J. Masugi, Y. Tamori, H. Mori, T. Koike, and M. Kasuga, Inhibitory Effect of a Proline-to-Alanine Substitution at Codon 12 of Peroxisome Proliferator-Activated Receptor-?? 2 on Thiazolidinedione-Induced Adipogenesis, Biochemical and Biophysical Research Communications, vol.268, issue.1, pp.178-182, 2000.
DOI : 10.1006/bbrc.2000.2096

D. Altshuler, J. Hirschhorn, M. Klannemark, C. Lindgren, M. Vohl et al., The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes, Nat Genet, vol.26, pp.76-80, 2000.

J. Douglas, M. Erdos, R. Watanabe, A. Braun, C. Johnston et al., The Peroxisome Poliferator-Activated Receptor-??2 Pro12Ala Variant: Association With Type 2 Diabetes and Trait Differences, Diabetes, vol.50, issue.4, pp.886-890, 2001.
DOI : 10.2337/diabetes.50.4.886

J. Ek, G. Andersen, S. Urhammer, L. Hansen, B. Carstensen et al., Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-??2 (PPAR-??2) gene in relation to insulin sensitivity among glucose tolerant Caucasians, Diabetologia, vol.44, issue.9, pp.1170-1176, 2001.
DOI : 10.1007/s001250100629

K. Hara, T. Okada, K. Tobe, K. Yasuda, Y. Mori et al., The Pro12Ala Polymorphism in PPAR ??2 May Confer Resistance to Type 2 Diabetes, Biochemical and Biophysical Research Communications, vol.271, issue.1, pp.212-216, 2000.
DOI : 10.1006/bbrc.2000.2605

O. Vaccaro, F. Mancini, G. Ruffa, L. Sabatino, V. Colantuoni et al., Pro12Ala mutation in the peroxisome proliferator-activated receptor ??2 (PPAR??2) and severe obesity: a case???control study, International Journal of Obesity, vol.24, issue.9, pp.1195-1199, 2000.
DOI : 10.1038/sj.ijo.0801366

B. Beamer, C. Yen, R. Andersen, D. Muller, D. Elahi et al., Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-gamma2 gene with obesity in two Caucasian populations, Diabetes, vol.47, issue.11, pp.1806-1808, 1998.
DOI : 10.2337/diabetes.47.11.1806

M. Shuldiner, A. Beamer, B. Charpentier, G. Guy-grand, B. Froguel et al., H e r c b e r g S , P a s s i n g e B The Pro115Gln and Pro12Ala PPAR gamma gene mutations in obesity and type 2 diabetes, Int J Obes Relat Metab Disord, vol.24, pp.391-393, 2000.

S. Li, W. Chen, S. Srinivasan, E. Boerwinkle, and G. Berenson, The Peroxisome Proliferator-Activated Receptor-??2 Gene Polymorphism (Pro12Ala) Beneficially Influences Insulin Resistance and Its Tracking From Childhood to Adulthood: The Bogalusa Heart Study, Diabetes, vol.52, issue.5, pp.1265-1269, 2003.
DOI : 10.2337/diabetes.52.5.1265

D. Meyre, C. Lecoeur, J. Delplanque, S. Francke, V. Vatin et al., A genome-wide scan for childhood obesity-associated traits in French families shows significant linkage on chromosome 6q22, Diabetes, vol.53, pp.31-54, 2004.
URL : https://hal.archives-ouvertes.fr/hal-00094092

M. Rolland-cachera, T. Cole, M. Sempe, J. Tichet, C. Rossignol et al., Body Mass Index variations: centiles from birth to 87 years, Eur J Clin Nutr, vol.45, pp.13-21, 1991.

E. Poskitt, Defining childhood obesity: the relative body mass index (BMI), Acta Paediatrica, vol.39, issue.8, pp.961-963, 1995.
DOI : 10.1016/0026-0495(77)90082-8

L. Lafay, A. Basdevant, M. Charles, M. Vray, B. Balkau et al., Determinants and nature of dietary underreporting in a free-living population: the Fleurbaix Laventie Ville Sant?? (FLVS) study, International Journal of Obesity, vol.21, issue.7, pp.567-573, 1997.
DOI : 10.1038/sj.ijo.0800443

T. Cole, J. Freeman, and M. Preece, Body mass index reference curves for the UK, 1990., Archives of Disease in Childhood, vol.73, issue.1, pp.25-29, 1990.
DOI : 10.1136/adc.73.1.25

D. Matthews, J. Hosker, A. Rudenski, B. Naylor, D. Treacher et al., Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man, Diabetologia, vol.92, issue.7, pp.412-419, 1985.
DOI : 10.1007/BF00280883

R. Buzzetti, A. Petrone, M. Ribaudo, I. Alemanno, S. Zavarella et al., The common PPAR-??2 Pro12Ala variant is associated with greater insulin sensitivity, European Journal of Human Genetics, vol.12, issue.12, pp.1050-1054, 2004.
DOI : 10.1038/sj.ejhg.5201283

N. Risch, Searching for genetic determinants in the new millennium, Nature, vol.405, issue.6788, pp.847-856, 2000.
DOI : 10.1038/35015718

K. Lohmueller, C. Pearce, M. Pike, E. Lander, and J. Hirschhorn, Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease, Nature Genetics, vol.33, issue.2, pp.177-182, 2003.
DOI : 10.1038/ng1071

A. Doney, B. Fischer, J. Cecil, K. Boylan, F. Mcguigan et al., Association of the Pro12Ala and C1431T variants of PPARG and their haplotypes with susceptibility to Type 2 diabetes, Diabetologia, vol.47, issue.3, pp.555-558, 2004.
DOI : 10.1007/s00125-003-1323-1

T. Yamauchi, J. Kamon, H. Waki, K. Murakami, K. Motojima et al., The Mechanisms by Which Both Heterozygous Peroxisome Proliferator-activated Receptor ?? (PPAR??) Deficiency and PPAR?? Agonist Improve Insulin Resistance, Journal of Biological Chemistry, vol.276, issue.44, pp.41245-41254, 2001.
DOI : 10.1074/jbc.M103241200

N. Kubota, Y. Terauchi, H. Miki, H. Tamemoto, T. Yamauchi et al., PPAR?? Mediates High-Fat Diet???Induced Adipocyte Hypertrophy and Insulin Resistance, Molecular Cell, vol.4, issue.4, pp.597-609, 1999.
DOI : 10.1016/S1097-2765(00)80210-5
URL : http://doi.org/10.1016/s1097-2765(00)80210-5

P. Miles, Y. Barak, W. He, R. Evans, and J. Olefsky, Improved insulin-sensitivity in mice heterozygous for PPAR-?? deficiency, Journal of Clinical Investigation, vol.105, issue.3, pp.287-292, 2000.
DOI : 10.1172/JCI8538

P. Tontonoz, E. Hu, R. Graves, A. Budavari, and B. Spiegelman, mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer., Genes & Development, vol.8, issue.10, pp.1224-1234, 1994.
DOI : 10.1101/gad.8.10.1224

M. Stumvoll and H. Haring, The Peroxisome Proliferator-Activated Receptor-??2 Pro12Ala Polymorphism, Diabetes, vol.51, issue.8, pp.2341-2347, 2002.
DOI : 10.2337/diabetes.51.8.2341

G. Boden, Free Fatty Acids, Insulin Resistance, and Type 2 Diabetes Mellitus, Proceedings of The Association of American Physicians, vol.44, issue.3, pp.241-248, 1999.
DOI : 10.1046/j.1525-1381.1999.99220.x